Fresh Tracks Therapeutics Inc.
Fresh Tracks Therapeutics, Inc. does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.
Market Cap & Net Worth: Fresh Tracks Therapeutics Inc. (FRTX)
Fresh Tracks Therapeutics Inc. (PINK:FRTX) has a market capitalization of $4.30 Million ($4.30 Million) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #33024 globally and #10806 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Fresh Tracks Therapeutics Inc.'s stock price $0.72 by its total outstanding shares 5973310 (5.97 Million).
Fresh Tracks Therapeutics Inc. Market Cap History: 2022 to 2024
Fresh Tracks Therapeutics Inc.'s market capitalization history from 2022 to 2024. Data shows change from $8.96 Million to $4.30 Million (-40.56% CAGR).
Fresh Tracks Therapeutics Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Fresh Tracks Therapeutics Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.66x
Fresh Tracks Therapeutics Inc.'s market cap is 0.66 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $8.96 Million | $6.94 Million | -$20.66 Million | 1.29x | N/A |
| 2023 | $5.26 Million | $8.01 Million | -$5.69 Million | 0.66x | N/A |
Competitor Companies of FRTX by Market Capitalization
Companies near Fresh Tracks Therapeutics Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Fresh Tracks Therapeutics Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Fresh Tracks Therapeutics Inc. Historical Marketcap From 2022 to 2024
Between 2022 and today, Fresh Tracks Therapeutics Inc.'s market cap moved from $8.96 Million to $ 4.30 Million, with a yearly change of -40.56%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | $4.30 Million | -18.18% |
| 2023 | $5.26 Million | -41.33% |
| 2022 | $8.96 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 28th, 2025 the market cap of Fresh Tracks Therapeutics Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.30 Million USD |
| MoneyControl | $4.30 Million USD |
| MarketWatch | $4.30 Million USD |
| marketcap.company | $4.30 Million USD |
| Reuters | $4.30 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.